pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 396 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
gentamicin sulfate
Gentamicin Sulfate (gentamicin sulfate)
Bacterial Blepharoconjunctivitis
Fera Pharmaceuticals LLC
0 catalysts
Marketed
grass pollen [cocksfoot (Dactylis glomerata) + sweet vernal (Anthoxanthum odoratum) + rye (Lolium perenne) + meadow (Poa pratensis) + timothy (Phleum pratense)] allergen extract
Oralair
Grass Pollen Allergy
Greer Laboratories Inc
0 catalysts
Marketed
guaifenesin
Elixsure EX (guaifenesin)
Cough
Moberg Pharma AB
0 catalysts
← prev
page 11 of 14
next →
131
Pain89
Neurology1
Phase 2
ifenprodil
ifenprodil [INN]
Chronic Cough
Seyltx Inc
0 catalysts
Phase 2
ifetroban
Dyscorban (ifetroban)
Duchenne Muscular Dystrophy
$CPIXCUMBERLAND PHARMACEUTICALS INC
0 catalysts
Preclinical
incyclinide
Acute Lung Injury
CMTx Biotech Inc
0 catalysts
Marketed
ipratropium bromide
Ipratropium Bromide (ipratropium bromide)
Chronic Bronchitis
The Ritedose Corp
0 catalysts
Phase 3
itepekimab
Chronic Obstructive Pulmonary Disease (COPD)
Interleukin-33
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Preclinical
kynurenic acid
Idiopathic Pulmonary Fibrosis
BirchBioMed Inc
0 catalysts
Marketed
lefamulin acetate
Xenleta (lefamulin acetate)
Community-Acquired Bacterial Pneumonia
Nabriva Therapeutics US Inc
0 catalysts
Marketed
levalbuterol hydrochloride
Levalbuterol Hydrochloride (levalbuterol hydrochloride)
Bronchospasm
The Ritedose Corp
0 catalysts
Marketed
levalbuterol tartrate
Xopenex HFA (levalbuterol tartrate)
Bronchospasm
Lupin Ltd
0 catalysts
Marketed
levofloxacin
Levofloxacin (levofloxacin)
Acute Bacterial Sinusitis
Teva Pharmaceuticals USA Inc
0 catalysts
Marketed
lincomycin
Lincomycin (lincomycin)
Enteritis
Micro Labs USA Inc
0 catalysts
Marketed
lincomycin hydrochloride
Lincomycin Hydrochloride (lincomycin hydrochloride)
Bacterial Endocarditis
GeneYork Pharmaceuticals Group LLC
0 catalysts
Marketed
linezolid
Linezolid (linezolid)
Diabetic Foot Infection (DFI)
HQ Speciality Pharma
0 catalysts
Phase 1
lixumistat
lixumistat [INN]
Pancreatic Ductal Adenocarcinoma
Immunomet Therapeutics Inc
0 catalysts
Marketed
loratadine
Loratadine (loratadine)
Allergic Rhinitis
Guardian Drug Company Inc
0 catalysts
pre_registration
lorundrostat hydrobromide
Hypertension
$MLYSMineralys Therapeutics, Inc.
0 catalysts
Phase 2
luvomeran
Cystic Fibrosis
$VERXVertex, Inc.
0 catalysts
Marketed
mannitol
Bronchitol (mannitol)
Cystic Fibrosis
Arna Pharma Pty Ltd
0 catalysts
Phase 2
mecasermin rinfabate
Bronchopulmonary Dysplasia
Insulin-like growth factor 1 receptor
Chiesi Farmaceutici SpA
0 catalysts
Marketed
mepolizumab
Nucala (mepolizumab)
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
GlaxoSmithKline LLC
0 catalysts
Marketed
metaproterenol sulfate
Metaproterenol Sulfate (metaproterenol sulfate)
Asthma
Chartwell Pharmaceuticals LLC
0 catalysts
Marketed
modafinil
Modafinil (modafinil)
Obstructive Sleep Apnea
Appco Pharma LLC
0 catalysts
pre_registration
molgramostim
Molbreevi (molgramostim)
Lung Disease
$SVRASavara Inc
0 catalysts
Marketed
montelukast sodium
Montelukast Sodium (montelukast sodium)
Chronic Asthma
Senores Pharmaceuticals Inc
0 catalysts
Marketed
nafcillin sodium
Nafcillin Sodium (nafcillin sodium)
Bacterial Endocarditis
Claris Lifesciences Inc
0 catalysts
Phase 2
nemonoxacin
Taigexyn (nemonoxacin [INN])
Diabetic Foot Infection (DFI)
TaiGen Biotechnology Co Ltd
0 catalysts
Phase 3
nintedanib
NINTEDANIB (nintedanib)
Pterygium
Platelet-derived growth factor receptorVascular endothelial growth factor receptor
Cloudbreak Therapeutics LLC
0 catalysts